Horseb4CarT Thursday, 06/25/20 05:05:54 PM Re: marzan post# 291659 Post # of 299886 Ok so I listened carefully to LL’s talk. She did say there were about 3 dozen Brad’s (long survival patients) however what I heard was over multiple trials not just the dcvax phase 3 trial. That said, the phase 3 trial probably accounts for the significant majority of patients since the 331 I think compares to the other trial sizes of less than 100 patients each. Perhaps others of you message board members know the actual trial sizes? I also think that other immunotherapy than dcvax were potentially included by LL in her 3 dozen statements.